Swiss pharmaceutical plant dedicated in Casablanca

A US $ 13 million-worth pharmaceutical plant, affiliated to the Swiss group F. Goffman La Roche, was dedicated on Monday in the Casablanca industrial area of Nouaceur.

Chief Executive Officer of the Swiss subsidiary, Sami Zerilli, said the plant will specialize in manufacturing dry effervescent pharmaceutics according to the international standards of environment protection.

"This new site will allow us to triple our production capacity in order to meet the growing demand of our products," Zerelli, adding that the plant is also poised to satisfy the Maghreb region's demand as provided by recently signed agreements.

The pharmaceutics industry worldwide is rather plummeting and some sites have even been shut down, he noted, stressing that despite this international downtrend the Swiss group's commitment in Morocco "brings out our confidence towards the Kingdom, where we have been active for 43 years now."

"Morocco's stability and its democratic pattern have motivated our decision," he further said, adding that the Casablanca plant was built on a covered area of 3,500 square meters.

The Swiss group, created 100 years ago in Switzerland, ranks among the top grass of the international pharmaceutical groups spearheading in fields such as AIDS, cancer, hepatitis and grafts.